Fig. 3From: Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: a case reportDrive gene detecting during the treatment. a NGS analysis of EGFR exon 19 deletion mutation in February 2016. b Acquiring T790 M mutation with plasma after resistant to icotinib in February 2016. c NGS analysis of EGFR exon 19 deletion mutation in March 2017. d NGS analysis of EGFR T790 M mutation, as well as Leu792H mutation with plasma after resistant to AZD9291 in March 2017. e NGS analysis of EGFR exon 19 deletion mutation in December 2017. f NGS analysis of EGFR T790 M mutation, without Leu792H mutation any more with plasma after resistant to repeating icotinib in December 2017Back to article page